Whole-exome sequencing identifies SGCD and ACVRL1 mutations associated with total anomalous pulmonary venous return (TAPVR) in Chinese population

Oncotarget. 2017 Apr 25;8(17):27812-27819. doi: 10.18632/oncotarget.15434.

Abstract

As a rare type of Congenital Heart Defects (CHD), the genetic mechanism of Total Anomalous Pulmonary Venous Return (TAPVR) remains unknown, although previous studies have revealed potential disease-driving regions/genes. Blood samples collected from the 6 sporadic TAPVR cases and 81 non-TAPVR controls were subjected to whole exome sequencing. All detected variations were confirmed by direct Sanger sequencing. Here, we identified 2 non-synonymous missense mutations: c.C652T, p.R218W in activin A receptor type II-like 1 (ACVRL1), c.C717G, p.D239E in sarcoglycan delta (SGCD). Our results offered the landscape of mutations for TAPVR in Chinese population firstly and are valuable in the mutation-based pre- and post-natal screening and genetic diagnosis for TAPVR.

Keywords: congenital disease; genetics; rare genetic variant; total anomalous pulmonary venous return (TAPVR); whole-exome sequencing (WES).

MeSH terms

  • Activin Receptors, Type II / genetics*
  • Adolescent
  • Asian People / genetics
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Computed Tomography Angiography
  • Echocardiography
  • Electrocardiography
  • Exome Sequencing
  • Female
  • Humans
  • Infant
  • Male
  • Mutation, Missense
  • Rare Diseases / diagnostic imaging
  • Rare Diseases / genetics*
  • Rare Diseases / surgery
  • Sarcoglycans / genetics*
  • Scimitar Syndrome / diagnostic imaging
  • Scimitar Syndrome / genetics*
  • Scimitar Syndrome / surgery

Substances

  • SGCD protein, human
  • Sarcoglycans
  • ACVRL1 protein, human
  • Activin Receptors, Type II